Increased prevalence of methanosphaera stadtmanae in inflammatory bowel diseases

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lecours, Pascale Blais ^a   Marsolais, David ^a,b   Cormier, Yvon ^a,b   Berberi, Marie ^c   Haché, Chantal ^c   Bourdages, Raymond ^c   Duchaine, Caroline ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CSSS Alphonse Desjardins   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COUNT; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLAMMATORY BOWEL DISEASE; MALE; METHANOBREVIBACTER SMITHII; METHANOGEN; METHANOSPHAERA STADTMANAE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; ULCERATIVE COLITIS;

ADULT; BLOTTING, WESTERN; CANADA; CASE-CONTROL STUDIES; CYTOKINES; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; METHANOBACTERIACEAE; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84894640438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087734     Document Type: Article

References (48)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, et al. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54, e42; quiz e30.
2. Burisch J, Jess T, Martinato M, Lakatos PL (2013) The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7: 322-337.
3. Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
4. Abraham C, Medzhitov R (2011) Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140: 1729-1737.
5. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. (Pubitemid 47123518)
6. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
7. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429.
8. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottiere HM, et al. (2013) A metagenomic insight into our gut's microbiome. Gut 62: 146-158.
9. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL (2012) IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 9: 219-230.
10. Sha S, Xu B, Wang X, Zhang Y, Wang H, et al. (2012) The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn Microbiol Infect Dis.
11. Manichanh C, Borruel N, Casellas F, Guarner F (2012) The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599-608.
12. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189.
13. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421. (Pubitemid 39091889)
14. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A (1999) Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 67: 4499-4509. (Pubitemid 29400425)
15. Barnich N, Denizot J, Darfeuille-Michaud A (2010) E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients. Pathol Biol (Paris).
16. Kaakoush NO, Mitchell HM (2012) Campylobacter concisus - A New Player in Intestinal Disease. Front Cell Infect Microbiol 2: 4.
17. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, et al. (2010) Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 16: 1008-1016.
18. Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, et al. (2004) Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 42: 2766-2768. (Pubitemid 38747533)
19. Man SM, Zhang L, Day AS, Leach S, Mitchell H (2008) Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter 13: 234-238.
20. Morvan B, Bonnemoy F, Fonty G, Gouet P (1996) Quantitative determination of H2-utilizing acetogenic and sulfate-reducing bacteria and methanogenic archaea from digestive tract of different mammals. Curr Microbiol 32: 129-133.
21. Miller TL, Wolin MJ, Conway de Macario E, Macario AJ (1982) Isolation of Methanobrevibacter smithii from human feces. Appl Environ Microbiol 43: 227-232. (Pubitemid 12137605)
22. Dridi B, Henry M, El Khechine A, Raoult D, Drancourt M (2009) High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 4: e7063.
23. Dridi B, Raoult D, Drancourt M (2011) Archaea as emerging organisms in complex human microbiomes. Anaerobe 17: 56-63.
24. Nakamura N, Lin HC, McSweeney CS, Mackie RI, Gaskins HR (2010) Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease. Annu Rev Food Sci Technol 1: 363-395.
25. Samuel BS, Hansen EE, Manchester JK, Coutinho PM, Henrissat B, et al. (2007) Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci U S A 104: 10643-10648. (Pubitemid 47185718)
26. Stams AJ (1994) Metabolic interactions between anaerobic bacteria in methanogenic environments. Antonie Van Leeuwenhoek 66: 271-294.
27. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638. (Pubitemid 40807514)
28. Pochart P, Lemann F, Flourie B, Pellier P, Goderel I, et al. (1993) Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology 105: 1281-1285. (Pubitemid 23315299)
29. Scanlan PD, Shanahan F, Marchesi JR (2008) Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol 8: 79.
30. Blais Lecours P, Duchaine C, Taillefer M, Tremblay C, Veillette M, et al. (2011) Immunogenic properties of archaeal species found in bioaerosols. PLoS One 6: e23326.
31. Yamabe K, Maeda H, Kokeguchi S, Tanimoto I, Sonoi N, et al. (2008) Distribution of Archaea in Japanese patients with periodontitis and humoral immune response to the components. FEMS Microbiol Lett 287: 69-75.
32. Hirai K, Maeda H, Omori K, Yamamoto T, Kokeguchi S, et al. (2013) Serum antibody response to group II chaperonin from Methanobrevibacter oralis and human chaperonin CCT. Pathog Dis 68: 12-19.
33. Million M, Maraninchi M, Henry M, Armougom F, Richet H, et al. (2012) Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond) 36: 817-825.
34. Fricke WF, Seedorf H, Henne A, Kruer M, Liesegang H, et al. (2006) The genome sequence of Methanosphaera stadtmanae reveals why this human intestinal archaeon is restricted to methanol and H2 for methane formation and ATP synthesis. J Bacteriol 188: 642-658. (Pubitemid 43100552)
35. Johnston C, Ufnar JA, Griffith JF, Gooch JA, Stewart JR (2010) A real-time qPCR assay for the detection of the nifH gene of Methanobrevibacter smithii, a potential indicator of sewage pollution. J Appl Microbiol 109: 1946-1956.
36. Steinberg LM, Regan JM (2009) mcrA-targeted real-time quantitative PCR method to examine methanogen communities. Appl Environ Microbiol 75: 4435-4442.
37. Steinberg LM, Regan JM (2008) Phylogenetic comparison of the methanogenic communities from an acidic, oligotrophic fen and an anaerobic digester treating municipal wastewater sludge. Appl Environ Microbiol 74: 6663-6671.
38. Bach HJ, Hartmann A, Schloter M, Munch JC (2001) PCR primers and functional probes for amplification and detection of bacterial genes for extracellular peptidases in single strains and in soil. J Microbiol Methods 44: 173-182. (Pubitemid 32124783)
39. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402. (Pubitemid 27359211)
40. Saleh M, Elson CO (2011) Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34: 293-302.
41. Feng T, Wang L, Schoeb TR, Elson CO, Cong Y (2010) Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 207: 1321-1332.
42. Petersen AM, Schou C, Mirsepasi H, Engberg J, Friis-Moller A, et al. (2012) Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection. Scand J Gastroenterol 47: 155-161.
43. Bogdanos DP, Rigopoulou EI, Smyk DS, Roggenbuck D, Reinhold D, et al. (2011) Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev 11: 143-148.
44. Chen CS, Sullivan S, Anderson T, Tan AC, Alex PJ, et al. (2009) Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol Cell Proteomics 8: 1765-1776.
45. Swidsinski A, Loening-Baucke V, Bengmark S, Lochs H, Dorffel Y (2007) Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis 13: 51-56. (Pubitemid 46080009)
46. Holland JL, Louie L, Simor AE, Louie M (2000) PCR detection of Escherichia coli O157:H7 directly from stools: evaluation of commercial extraction methods for purifying fecal DNA. J Clin Microbiol 38: 4108-4113. (Pubitemid 32233212)
47. Iijima Y, Asako NT, Aihara M, Hayashi K (2004) Improvement in the detection rate of diarrhoeagenic bacteria in human stool specimens by a rapid real-time PCR assay. J Med Microbiol 53: 617-622. (Pubitemid 38932358)
48. Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70: 3575-3581. (Pubitemid 38745906)